These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 26198255)
1. Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease. Hernandez-Chan NG; Bannon MJ; Orozco-Barrios CE; Escobedo L; Zamudio S; De la Cruz F; Gongora-Alfaro JL; Armendáriz-Borunda J; Reyes-Corona D; Espadas-Alvarez AJ; Flores-Martínez YM; Ayala-Davila J; Hernandez-Gutierrez ME; Pavón L; García-Villegas R; Nadella R; Martinez-Fong D J Biomed Sci; 2015 Jul; 22(1):59. PubMed ID: 26198255 [TBL] [Abstract][Full Text] [Related]
2. The transfection of BDNF to dopamine neurons potentiates the effect of dopamine D3 receptor agonist recovering the striatal innervation, dendritic spines and motor behavior in an aged rat model of Parkinson's disease. Razgado-Hernandez LF; Espadas-Alvarez AJ; Reyna-Velazquez P; Sierra-Sanchez A; Anaya-Martinez V; Jimenez-Estrada I; Bannon MJ; Martinez-Fong D; Aceves-Ruiz J PLoS One; 2015; 10(2):e0117391. PubMed ID: 25693197 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease. Sun M; Kong L; Wang X; Lu XG; Gao Q; Geller AI Brain Res; 2005 Aug; 1052(2):119-29. PubMed ID: 16018990 [TBL] [Abstract][Full Text] [Related]
8. Optimizing NTS-polyplex as a tool for gene transfer to cultured dopamine neurons. Hernandez-Baltazar D; Martinez-Fong D; Trudeau LE PLoS One; 2012; 7(12):e51341. PubMed ID: 23300540 [TBL] [Abstract][Full Text] [Related]
9. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease. Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786 [TBL] [Abstract][Full Text] [Related]
10. A comprehensive study on long-term injury to nigral dopaminergic neurons following intracerebroventricular injection of lipopolysaccharide in rats. Zhou Y; Zhang Y; Li J; Lv F; Zhao Y; Duan D; Xu Q J Neurochem; 2012 Dec; 123(5):771-80. PubMed ID: 22957701 [TBL] [Abstract][Full Text] [Related]
11. NTS-Polyplex: a potential nanocarrier for neurotrophic therapy of Parkinson's disease. Martinez-Fong D; Bannon MJ; Trudeau LE; Gonzalez-Barrios JA; Arango-Rodriguez ML; Hernandez-Chan NG; Reyes-Corona D; Armendáriz-Borunda J; Navarro-Quiroga I Nanomedicine; 2012 Oct; 8(7):1052-69. PubMed ID: 22406187 [TBL] [Abstract][Full Text] [Related]
12. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079 [TBL] [Abstract][Full Text] [Related]
13. In vivo gene transfer to dopamine neurons of rat substantia nigra via the high-affinity neurotensin receptor. Alvarez-Maya I; Navarro-Quiroga I; Meraz-Ríos MA; Aceves J; Martinez-Fong D Mol Med; 2001 Mar; 7(3):186-92. PubMed ID: 11471555 [TBL] [Abstract][Full Text] [Related]
14. Synthetic Monopartite Peptide That Enables the Nuclear Import of Genes Delivered by the Neurotensin-Polyplex Vector. Lopez-Salas FE; Nadella R; Maldonado-Berny M; Escobedo-Sanchez ML; Fiorentino-Pérez R; Gatica-García B; Fernandez-Parrilla MA; Mario Gil M; Reyes-Corona D; García U; Orozco-Barrios CE; Gutierrez-Castillo ME; Martinez-Fong D Mol Pharm; 2020 Dec; 17(12):4572-4588. PubMed ID: 33125243 [TBL] [Abstract][Full Text] [Related]
15. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089 [TBL] [Abstract][Full Text] [Related]
16. Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease. Lin JG; Chen CJ; Yang HB; Chen YH; Hung SY Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837077 [TBL] [Abstract][Full Text] [Related]
17. Small molecule TrkB agonist deoxygedunin protects nigrostriatal dopaminergic neurons from 6-OHDA and MPTP induced neurotoxicity in rodents. Nie S; Xu Y; Chen G; Ma K; Han C; Guo Z; Zhang Z; Ye K; Cao X Neuropharmacology; 2015 Dec; 99():448-58. PubMed ID: 26282118 [TBL] [Abstract][Full Text] [Related]
18. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD). Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049 [TBL] [Abstract][Full Text] [Related]
19. Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. Levivier M; Przedborski S; Bencsics C; Kang UJ J Neurosci; 1995 Dec; 15(12):7810-20. PubMed ID: 8613721 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms. Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]